In Focus
In Focus is our regular bi-monthly newsletter which updates our clients on latest product development, topical issues affecting the insurance market, future events and up to date information on Hannover Life Re (UK).
In_Focus_Issue_49
Simple, packaged or prescribed?
-This article takes us through the key themes in the delivery of protection propostions. The aim for our industry is to create products that are easily accessible to consumers and which also meet their basic needs.
Quality counts
Both the quantity and quality of data are important. It is easy to measure the quantity of data - but how do we measure quality?
Saving for a rainy day
In these uncertain times, rainy day funds seem more important than ever.
PDF
(2.69 MB)
In Focus Issue 48
Gender - still more questions than answers
-This article takes us through the issues faced on gender discrimination in the insurance market.
Living in the here and now
Consumer inertia has been a perenial problem for our industry.
Terminal Illness: A Critical illness benefit or a death benefit
Terminal illness cover has been available in the UK for many years and is now almost universally added to life term policies.
Fairer care funding
Reforming the funding of adult social care.
Protection horizon - storm ahead or clear skies
Overview of our 13th annual seminar.
PDF
(8.49 MB)
In Focus Issue 47
Enhanced annuities in the UK
- Christine Dahlke, Actuary in the Life Department in Germany takes us through the enhanced annuity market and how it has grown since its beginings in 1995 from a niche market to a substantial volume product
Look before you leap
Looking at other risks other than medical risks such as avocational risk of hazardous hobbies like parachuting etc
Ahead of the Curve - A time to reflect and move on
PDF
(5.98 MB)
In Focus Issue 46
Bad Blood: a cell too many
- This article discusses the haematological condition 'Polycythaemia Vera' and the implications for risk management.
Alport's Syndrome - much worse than a kick to the kidneys
This renal disorder claims responsibility for a select number of renal failure cases annually and we consider the diagnostic and therapeutic approaches and its implications for life insurance risk management.
PDF
(2.47 MB)
